Ultragenyx Pharmaceutical Inc. (RARE) Social Stream



Ultragenyx Pharmaceutical Inc. (RARE): $47.34

2.10 (+4.64%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add RARE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 401

in industry

ULTRAGENYX PHARMACEUTICAL INC (RARE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering ULTRAGENYX PHARMACEUTICAL INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-05 16 $185 $73 $146.2 $42.98 240.16%
2022-01-11 16 $185 $73 $143.933 $42.98 234.88%
2022-01-25 16 $185 $73 $143 $42.98 232.71%
2022-01-26 16 $185 $73 $142.4 $42.98 231.32%
2022-01-31 16 $185 $73 $140 $42.98 225.73%
2022-02-11 16 $185 $73 $140 $42.98 225.73%
2022-02-14 15 $185 $73 $139.466 $42.98 224.49%
2022-04-26 15 $186 $73 $139.533 $42.98 224.65%
2022-04-28 15 $186 $73 $139.666 $42.98 224.96%
2022-05-05 15 $186 $73 $138.461 $42.98 222.15%
2022-05-09 13 $186 $71 $129.538 $42.98 201.39%
2022-05-18 13 $186 $71 $126.846 $42.98 195.13%
2022-05-24 14 $186 $71 $125 $42.98 190.83%
2022-07-28 13 $185 $70 $121.5 $42.98 182.69%
2022-08-01 14 $185 $68 $117 $42.98 172.22%
2022-08-02 14 $185 $60 $112.666 $42.98 162.14%
2022-08-13 14 $185 $60 $114.5 $42.98 166.4%
2022-09-17 13 $185 $60 $117.266 $42.98 172.84%
2022-10-12 11 $185 $60 $117.266 $42.98 172.84%
2022-10-21 13 $185 $50 $112 $42.98 160.59%
2022-10-25 13 $185 $50 $111.5 $42.98 159.42%
2022-11-03 14 $164 $49 $102.312 $42.98 138.05%
2022-11-04 14 $143 $49 $101 $42.98 134.99%
2022-12-07 14 $143 $49 $98.125 $42.98 128.3%
2022-12-13 14 $143 $49 $94.937 $42.98 120.89%
2023-01-13 15 $143 $49 $94.176 $42.98 119.12%
2023-01-26 15 $143 $48 $94.117 $42.98 118.98%

The Trend in the Analyst Price Target


RARE's average price target has moved down $62.88 over the prior 23 months.

Over the past 51 weeks, RARE's average upside potential has been 130.3%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-19 15 186 73 139.533 78.10 78.66%
2022-09-17 12 185 60 117.266 46.03 154.76%
2022-10-13 13 185 50 112.000 39.65 182.47%
2022-10-21 13 185 50 111.500 38.49 189.69%
2023-01-08 15 143 49 94.176 46.66 101.83%

RARE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.43 11 1 3 0 0 15

The Trend in the Broker Recommendations


Over the past 153 days, RARE's average broker recommendation rating improved by 0.32.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • RARE has a higher upside potential (average analyst target price relative to current price) than 2881.11% of stocks in the large market cap category.
  • ULTRAGENYX PHARMACEUTICAL INC's number of analysts covering the stock is greater than 2759.1% of Pharmaceutical Products stocks.
  • ULTRAGENYX PHARMACEUTICAL INC's average analyst price target is greater than 2723.69% of Pharmaceutical Products stocks.
  • RARE has a lower variance in analysts' estimates than -2594.52% of stocks in the large market cap category.

Stocks similar to ULTRAGENYX PHARMACEUTICAL INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CTLT, TEVA, and PRGO.

Is RARE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6863 seconds.